Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Cited by (692)

Items 201–300 of 692

1. Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers
   Yao Shen, Jiaxin Hong, Ryoichi Asaka, Shiho Asaka, Fang‐Chi Hsu, Yohan Suryo Rahmanto, Jin-Gyoung Jung, Yu-Wei Chen, Ting‐Tai Yen, Alicja Tomaszewski et al. · 2020 · Cancer Research
2. Extracellular Flux Analysis to Monitor Glycolytic Rates and Mitochondrial Oxygen Consumption
   Martin Pelletier, Leah K. Billingham, Madhu Ramaswamy, Richard M. Siegel · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
3. Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response
   Roberta Palorini, Francesco Paolo Cammarata, Chiara Balestrieri, Andrea Monestiroli, Michele Vasso, Cecilia Gelfi, Lilia Alberghina, Ferdinando Chiaradonna · 2013 · Cell Death and Disease
4. α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis
   Sandra Atlante, Alessia Visintin, Elisabetta Marini, Matteo Savoia, Chiara Dianzani, Marta Giorgis, Duran Sürün, Federica Maione, Frank Schnütgen, Antonella Farsetti et al. · 2018 · Cell Death and Disease
5. Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells
   Mercedes Martín‐Rufián, Renata Nascimento-Gomes, Ana Higuero, Amanda Rabello Crisma, José Angel Campos-Sandoval, María C. Gómez-García, Carolina Cardona, Tzuling Cheng, Carolina Lobo, Juan A. Segura et al. · 2013 · Journal of Molecular Medicine
6. ErbB2 Activation Upregulates Glutaminase 1 Expression Which Promotes Breast Cancer Cell Proliferation
   Shuo Qie, Clarissa Chu, Weihua Li, Chenguang Wang, Nianli Sang · 2013 · Journal of Cellular Biochemistry
7. Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling
   Xiaohu Tang, C-K Ding, Jianli Wu, Jessie Sjol, Suzanne E. Wardell, Ivan Spasojević, Daniel J. George, Donald Patrick McDonnell, David S. Hsu, Jeffrey T. Chang et al. · 2016 · Oncogene
8. NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome
   Christopher W. Armstrong, Neil McGregor, John R. Sheedy, Ian H Buttfield, Henry L. Butt, Paul R. Gooley · 2012 · Clinica Chimica Acta
9. Activated lymphocytes as a metabolic model for carcinogenesis
   Andrew N. Macintyre, Jeffrey C. Rathmell · 2013 · Cancer & Metabolism
10. Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma
    Boris I. Ratnikov, Pedro Aza‐Blanc, Ze’ev A. Ronai, Jeffrey W. Smith, Andrei L. Osterman, David A. Scott · 2015 · Oncotarget
11. Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas
    Xiaohu Tang, Jianli Wu, Chien‐Kuang Cornelia Ding, Min Lu, Melissa M. Keenan, Chao‐Chieh Lin, Chih-An Lin, Charles C. Wang, Daniel J. George, David S. Hsu et al. · 2016 · Cancer Research
12. Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells
    Bernfeld, Elyssa, Foster, David A. · 2019 · Trends in Endocrinology & Metabolism
13. Targeting GLS1 to cancer therapy through glutamine metabolism
    Wei Yu, Xiangyu Yang, Qian Zhang, Li Sun, Shengtao Yuan, Yongjie Xin · 2021 · Clinical & Translational Oncology
14. DDIT3 Directs a Dual Mechanism to Balance Glycolysis and Oxidative Phosphorylation during Glutamine Deprivation
    Mingyue Li, Rick Francis Thorne, Ronghua Shi, Xu Dong Zhang, Jingmin Li, Jingtong Li, Qingyuan Zhang, Mian Wu, Lianxin Liu · 2021 · Advanced Science
15. The role of RNA alternative splicing in regulating cancer metabolism
    Itamar Kozlovski, Zahava Siegfried, Adi Amar-Schwartz, Rotem Karni · 2017 · Human Genetics
16. Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells
    Patel, Deven, Menon, Deepak, Bernfeld, Elyssa, Mroz, Victoria, Kalan, Sampada, Loayza, Diego, Foster, David A. · 2016 · Journal of Biological Chemistry
17. B-Cell Metabolic Remodeling and Cancer
    Davide G. Franchina, Melanie Grusdat, Dirk Brenner · 2018 · Trends in cancer
18. Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis
    Bin Jiang, Jia Zhang, Guohui Zhao, Mengjue Liu, Jielu Hu, Furong Lin, Jinyang Wang, Wentao Zhao, Huanhuan Ma, Cixiong Zhang et al. · 2021 · Molecular Cell
19. Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling
    Yuan Cao, Shuhai Lin, Yongbin Wang, Yue Eugene Chin, Lan Kang, Jun Mi · 2017 · Theranostics
20. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming
    Bernadette M. M. Zwaans, David B. Lombard · 2014 · Disease Models & Mechanisms
21. Emerging Metabolic Targets in Cancer Therapy
    Yuhua Zhao · 2010 · Frontiers in bioscience
22. A therapeutic role for targeting c-Myc/Hif-1- dependent signaling pathways
    Klaus Podar, Kenneth Carl Anderson · 2010 · Cell Cycle
23. Prolyl hydroxylases as regulators of cell metabolism
    Boulahbel, Houda, Durán, Raúl V., Gottlieb, Eyal · 2009 · Biochemical Society Transactions
24. MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
    Vincent Tambay, Valérie‐Ann Raymond, Marc Bilodeau · 2021 · Cancers
25. Androgen-regulated metabolism and biosynthesis in prostate cancer
    Stefan J. Barfeld, Harri M. Itkonen, Alfonso Urbanucci, Ian Geoffrey Mills · 2014 · Endocrine Related Cancer
26. Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
    Casterland Marbaniang, Lakhan Kma · 2018 · Europe PMC (PubMed Central)
27. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
    Christina H. Eng, Robert T. Abraham · 2011 · Oncogene
28. MYC‐driven inhibition of the glutamate‐cysteine ligase promotes glutathione depletion in liver cancer
    Brittany N. Anderton, Roman Camarda, Sanjeev Balakrishnan, Asha Balakrishnan, Rebecca A. Kohnz, Lionel Lim, Kimberley Jane Evason, Olga Momčilović, Klaus Kruttwig, Qiang Huang et al. · 2017 · EMBO Reports
29. The MYC mRNA 3′‐UTR couples RNA polymerase II function to glutamine and ribonucleotide levels
    Francesca R. Dejure, Nadine Royla, Steffi Herold, Jacqueline Kalb, Susanne Walz, Carsten Patrick Ade, Guido Mastrobuoni, Jens T. Vanselow, Andreas Schlösser, Elmar Wolf et al. · 2017 · The EMBO Journal
30. Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment
    Yao Shen, Chi‐Long Chen, Yi‐Hsuan Huang, Emily Elizabeth Evans, Chun‐Chia Cheng, Ya-Jie Chuang, Cissy Zhang, Anne Le · 2021 · Current Opinion in Chemical Biology
31. Hyperpolarized 13C Spectroscopic Imaging Informs on Hypoxia-Inducible Factor-1 and Myc Activity Downstream of Platelet-Derived Growth Factor Receptor
    Hagit Dafni, Peder E. Z. Larson, Simon Hu, Hikari A. I. Yoshihara, Christopher Scott Ward, Humsa S. Venkatesh, Chunsheng Wang, Xiaoliang Zhang, Daniel B. Vigneron, Sabrina M. Ronen · 2010 · Cancer Research
32. Glucose deprivation induces an atypical form of apoptosis mediated by caspase-8 in Bax-, Bak-deficient cells
    Alfredo Caro‐Maldonado, Stephen W. G. Tait, Silvia Ramírez‐Peinado, Jean‐Ehrland Ricci, Isabel Fabregat, Douglas R. Green, Cristina Muñoz‐Pinedo · 2010 · Cell Death and Differentiation
33. Side Effects of Amino Acid Supplements
    Milan Holeček · 2022 · Physiological Research
34. A Glutaminase Isoform Switch Drives Therapeutic Resistance and Disease Progression of Prostate Cancer
    Lingfan Xu, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang, Juan Liu, James Beasley, Patricia McCaw, Haoyue Zhang et al. · 2020 · Proceedings of the National Academy of Sciences
35. Metabolism of asparagine in the physiological state and cancer
    Qiong Yuan, Liyang Yin, Jun He, Qiting Zeng, Yuxin Liang, Yingying Shen, Xuyu Zu · 2024 · Cell Communication and Signaling
36. Mitochondria and ferroptosis
    Sabzali A. Javadov · 2022 · Current Opinion in Physiology
37. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
    Ruiyuan Xu, Jinshou Yang, Bo Ren, Huanyu Wang, Gang Yang, Yuan Chen, Lei You, Yupei Zhao · 2020 · Frontiers in Oncology
38. Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic Reprogramming during G1
    Marc Elgort, J. M. O'Shea, Yike Jiang, Donald E. Ayer · 2010 · Genes & Cancer
39. Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
    Austin R. Pantel, Daniel Ackerman, Seung‐Cheol Lee, David A. Mankoff, Terence P.F. Gade · 2018 · Journal of Nuclear Medicine
40. The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity
    Md Nabiul Hasan, Okan Capuk, Shivani M. Patel, Dandan Sun · 2022 · Cancers
41. Determinants of nutrient limitation in cancer
    Mark R. Sullivan, Matthew G. Vander Heiden · 2019 · Critical Reviews in Biochemistry and Molecular Biology
42. Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer
    Chunxiao Zhou, Hui Guo, Adam K. Willson, Lingqin Yuan, Hannah M. Jones, Paola A. Gehrig, Xiugui Sheng, Zhang, Lu, Leslie Horn Clark, Victoria Lin Bae-Jump · 2020 · PubMed Central
43. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
    Olga N. Aprelikova, Kenny Chen, Lara H. El Touny, Constance Brignatz, Justin S. Han, Tinghu Qiu, Howard Hua Yang, Maxwell P. Lee, Min Zhu, Jeffrey E. Green · 2016 · Clinical Epigenetics
44. Taking on Challenging Targets: Making MYC Druggable
    Dai Horiuchi, Brittany N. Anderton, Andrei Goga · 2014 · American Society of Clinical Oncology Educational Book
45. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
    Jennifer F. Barger, David R. Plas · 2010 · Endocrine Related Cancer
46. Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters
    L Gan, R Xiu, Ping Ren, M Yue, Hui Su, G Guo, Daibiao Xiao, Jiazhi Yu, Hualiang Jiang, Haigang Liu et al. · 2015 · Oncogene
47. Kinase Suppressor of Ras 1 (KSR1) Regulates PGC1α and Estrogen-Related Receptor α To Promote Oncogenic Ras-Dependent Anchorage-Independent Growth
    Kurt W. Fisher, Binita Das, Robert L. Kortum, Oleg V. Chaika, Robert E. Lewis · 2011 · Molecular and Cellular Biology
48. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α
    Cheng Yeh Chen, Shaoxin Cai, Guihua Wang, Xiaonian Cao, Xi Yang, Xuelai Luo, Yongdong Feng, Junbo Hu · 2012 · Biochemical and Biophysical Research Communications
49. The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy
    Hoerner, Christian R., Chen, Viola J., Fan, Alice C. · 2019 · Kidney Cancer
50. In vivo Reprogramming of Cancer Metabolism by MYC
    Roman Camarda, Jeremy R. Williams, Andrei Goga · 2017 · Frontiers in Cell and Developmental Biology
51. Crosstalk between metabolism and cell death in tumorigenesis
    Shichao Yang, Caden Hu, Xiaomei Chen, Yi Tang, Juanjuan Li, Hanqing Yang, Yi Yang, Binwu Ying, Xue Xiao, Shang‐Ze Li et al. · 2024 · Molecular Cancer
52. Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator β-glucan in a two-case ex vivo non-small-cell lung cancer study
    Teresa W.‐M. Fan, Marc O. Warmoes, Qiushi Sun, Huan Song, Jadwiga T. Turchan-Cholewo, Jeremiah Thomas Martin, Angela L. Mahan, Richard M. Higashi, Andrew N. Lane · 2016 · Molecular Case Studies
53. PKM2 Tyrosine Phosphorylation and Glutamine Metabolism Signal a Different View of the Warburg Effect
    Chi Van Dang · 2009 · Science Signaling
54. Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase
    Pachiyappan Kamarajan, Thekkelnaycke M. Rajendiran, Jason Michael Kinchen, Mercedes Bermúdez, Theodora Danciu, Yvonne Lorraine Kapila · 2017 · Journal of Proteome Research
55. Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs
    Saqcena, M, Mukhopadhyay, S, Hosny, C, Alhamed, A, Chatterjee, A, Foster, D A · 2015 · Oncogene
56. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
    Maria Tunset Grinde, Bylgja Hilmarsdóttir, Hanna Maja Tunset, Ida Marie Henriksen, Jana Kim, Mads Haugland Haugen, Morten Beck Rye, Gunhild Mari Mælandsmo, Siver Andreas Moestue · 2019 · Breast Cancer Research
57. Acidosis Promotes Bcl-2 Family-mediated Evasion of Apoptosis
    Christopher B. Ryder, Karen S. McColl, Fei Zhong, Clark Distelhorst · 2012 · Journal of Biological Chemistry
58. Metabolic changes during ovarian cancer progression as targets for sphingosine treatment
    Angela S. Anderson, Paul C. Roberts, Madlyn I. Frisard, Ryan P. McMillan, Timothy J. Brown, Michael H. Lawless, Matthew W. Hulver, Eva M. Schmelz · 2013 · Experimental Cell Research
59. Glutamine supplementation enhances development of in vitro-produced porcine embryos and increases leucine consumption from the medium†
    Paula R. Chen, Bethany K. Redel, Lee D. Spate, Tieming Ji, Shirley Rojas Salazar, Randall S. Prather · 2018 · Biology of Reproduction
60. Enigmatic MYC Conducts an Unfolding Systems Biology Symphony
    Chi Van Dang · 2010 · Genes & Cancer
61. Human Cytomegalovirus: Coordinating Cellular Stress, Signaling, and Metabolic Pathways
    Thomas E. Shenk, James C. Alwine · 2014 · Annual Review of Virology
62. Ammonia: A Diffusible Factor Released by Proliferating Cells That Induces Autophagy
    Guillermo Mariño, Guido Kroemer · 2010 · Science Signaling
63. Autophagy: a targetable linchpin of cancer cell metabolism
    Robert D. Leone, Ravi K. Amaravadi · 2013 · Trends in Endocrinology and Metabolism
64. Metabolic changes in cancer cells upon suppression of MYC
    Elena Ansó, Andrew R. Mullen, Dean W. Felsher, José Manuel Matés, Ralph J. DeBerardinis, Navdeep S. Chandel · 2013 · Cancer & Metabolism
65. On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
    Judith Penkert, Tim Ripperger, Maximilian Schieck, Brigitte Schlegelberger, Doris Steinemann, Thomas Illig · 2016 · Oncotarget
66. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4
    Lili Wang, Haisheng Zhou, Yong Wang, G Cui, L-J. Di · 2015 · Cell Death and Disease
67. Overview of Cancer Metabolism and Signaling Transduction
    Heesuk Chae, Seong‐Tshool Hong · 2022 · International Journal of Molecular Sciences
68. Metabolic reprogramming: a hallmark of viral oncogenesis
    Pierre L. Levy, Birke Bartosch · 2015 · Oncogene
69. Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma
    Dustin Rizzieri, Barry A. Paul, Yubin Kang · 2019 · Journal of Cancer Metastasis and Treatment
70. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
    Renata Ramalho, Martin Rao, Chao Zhang, Chiara Agrati, Giuseppe Ippolito, Fu‐Sheng Wang, Alimuddin I. Zumla, Markus J. Maeurer · 2020 · Seminars in Immunopathology
71. Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
    Katherine Sellers, Thaddeus D. Allen, Michael Bousamra, Jinlian Tan, Andrés Méndez‐Lucas, Wei Lin, Nourdine Kabirou Bah, Yelena Chernyavskaya, James I. MacRae, Richard M. Higashi et al. · 2019 · British Journal of Cancer
72. Mitochondrial metabolism and energy sensing in tumor progression
    Luisa Iommarini, Anna Maria Ghelli, Giuseppe Gasparre, Anna Maria Porcelli · 2017 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
73. RETRACTED: Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells
    Jing Li, Alfredo Csibi, Sun Yang, Gregory R. Hoffman, Chenggang Li, Erik Y. Zhang, Jane J. Yu, John Blenis · 2014 · Proceedings of the National Academy of Sciences · Retracted
74. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex
    Tingting Li, Yang Li, Tong Liu, Bingtao Hu, Jiabin Li, Chen Liu, Tao Liu, Feng Li · 2020 · Theranostics
75. Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation
    Chih-Yao Chung, Kritarth Singh, Vassilios N. Kotiadis, Gabriel E. Valdebenito, Jee Hwan Ahn, Emilie Topley, Joycelyn Tan, William D. Andrews, Benoît Bilanges, Robert D. S. Pitceathly et al. · 2021 · Nature Communications
76. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
    Shiv Bharadwaj, Mahendra Vikram Singh, Nikhil Kirtipal, Sang Gu Kang · 2021 · Frontiers in Molecular Biosciences
77. Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics
    Andrew N. Lane, Julie D. Tan, Yali Wang, Jun Yan, Richard M. Higashi, Teresa W.‐M. Fan · 2017 · Metabolic Engineering
78. MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
    Andrea Bisso, Arianna Sabò, Bruno B. Amati · 2019 · Immunological Reviews
79. Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
    Dean C. Singleton, Anne-Lise Dechaume, Pamela M. Murray, William P. Katt, Bruce C. Baguley, Euphemia Yee Leung · 2020 · BMC Cancer
80. FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress
    Roberto Ronca, Gaia Cristina Ghedini, Federica Maccarinelli, Antonio Sacco, Silvia L. Locatelli, Eleonora Foglio, Sara Taranto, Elisabetta Grillo, Sara Matarazzo, Riccardo Castelli et al. · 2020 · Cancer Research
81. Cell death-based treatment of neuroblastoma
    Kadri Valter, Boris Zhivotovsky, Vladimir G. Gogvadze · 2018 · Cell Death and Disease
82. NMR-based Stable Isotope Resolved Metabolomics in systems biochemistry
    Andrew N. Lane, Teresa W.‐M. Fan · 2017 · Archives of Biochemistry and Biophysics
83. Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
    Rui Ni, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, Yao Liu · 2023 · Frontiers in Oncology
84. c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity
    Tao Wang, Bolei Cai, Mingchao Ding, Zhongping Su, Yanpu Liu, Liangliang Shen · 2019 · The American Journal of the Medical Sciences
85. MYC-induced metabolic stress and tumorigenesis
    Adam J. Wolpaw, Chi Van Dang · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
86. SIRT7‐mediated modulation of glutaminase 1 regulates TGF‐β‐induced pulmonary fibrosis
    Malay Choudhury, Xueqian Yin, Kyle J. Schaefbauer, Jeong Han Kang, Bhaskar Roy, Theodore J. Kottom, ANDREW HAR LIMPER, Edward B. Leof · 2020 · The FASEB Journal
87. Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer
    Lewei Zheng, Cuicui Liu, Ke‐Da Yu · 2023 · Journal of Hematology & Oncology
88. Glutamine metabolism in cancer therapy
    Tra-Ly Nguyen, Raúl V. Durán · 2018 · Cancer Drug Resistance
89. Glutamine metabolic reprogramming in hepatocellular carcinoma
    Yanyan Ye, Bodong Yu, Hua Wang, F. Yi · 2023 · Frontiers in Molecular Biosciences
90. An extended Myc network contributes to glucose homeostasis in cancer and diabetes
    W. Peterson Christopher · 2011 · Frontiers in bioscience
91. Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion
    Yukiko Takeuchi, Yasumune Nakayama, Eiichiro Fukusaki, Yasuhiro Irino · 2017 · Biochemical and Biophysical Research Communications
92. Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
    Paola Falletta, Colin R. Goding, Yurena Vivas · 2022 · Frontiers in Cell and Developmental Biology
93. Glutamine at focus: versatile roles in cancer
    Humberto De Vitto, Juan Alberto Pérez-Valencia, James A. Radosevich · 2015 · Tumor Biology
94. Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence
    Claudio Vernieri, Francesca Ligorio, Debu Tripathy, Valter Daniel Longo · 2024 · Cell Metabolism
95. ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production
    Etienne Masle‐Farquhar, Angelika Bröer, Mehmet Yabas, Anselm Enders, Stefan Bröer · 2017 · Frontiers in Immunology
96. Chromosomal instability causes sensitivity to metabolic stress
    Zeeshan Shaukat, Dawei Liu, Amanda Choo, Rashid Hussain, Louise V. O’Keefe, Robert I. Richards, Robert B. Saint, Stephen L. Gregory · 2014 · Oncogene
97. CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function
    Chioniso Patience Masamha, Zheng Xia, Natoya J. Peart, Scott D. Collum, Wei Li, Eric J. Wagner, Ann‐Bin Shyu · 2016 · RNA
98. Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins
    Kimberly Romero Rosales, Gurpreet Singh, Kevin C.‐W. Wu, Jie Chen, Matthew Robert Janes, Michael B. Lilly, Eigen R. Peralta, Leah J. Siskind, Michael J. Bennett, David A. Fruman et al. · 2011 · Biochemical Journal
99. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers
    Markus Schick, Stefan Habringer, Jonas A. Nilsson, Ulrich Bernd Keller · 2017 · British Journal of Haematology
100. Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors
     Mengrou Shan, David L. Dai, Arunodai Vudem, Jeffrey D. Varner, Abraham Duncan Stroock · 2018 · PLoS Computational Biology